Proton Beam Therapy in Elderly Patients With cT1-3N0M0 Non-small Cell Lung Cancer

被引:5
作者
Nakamura, Masatoshi [1 ]
Ishikawa, Hitoshi [1 ,2 ]
Ohnishi, Kayoko [1 ,3 ]
Baba, Keiichiro [1 ]
Saito, Takashi [1 ]
Sumiya, Taisuke [1 ]
Murakami, Motohiro [1 ]
Hiroshima, Yuichi [1 ]
Nakai, Kei [1 ]
Mizumoto, Masashi [1 ]
Okumura, Toshiyuki [1 ]
Sakurai, Hideyuki [1 ]
机构
[1] Univ Tsukuba, Fac Med, Dept Radiat Oncol, Tsukuba, Ibaraki, Japan
[2] QST Hosp, Natl Inst Quantum Sci & Technol, Chiba, Japan
[3] Int Univ Hlth & Welf, Sch Med, Dept Radiol, Narita, Japan
关键词
Proton beam therapy; elderly patients; non-small cell lung cancer; BODY RADIATION-THERAPY; PNEUMONITIS; RADIOTHERAPY; IMPACT; DISEASE; SURVIVAL;
D O I
10.21873/anticanres.15778
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: To investigate the outcomes of elderly patients with cT1-3N0M0 non-small cell lung cancer (NSCLC) undergoing proton beam therapy (PBT). Patients and Methods: Between 2009 and 2019, 110 patients receiving hypofractionated PBT for cT1-3N0M0 NSCLC were retrospectively reviewed. Results: The median followup was 36.5 months (range=4.9-131.0 months). In the elderly group (80 years or older), the 3-year overall survival and progression-free survival rates were 79.8% and 73.9%, respectively, and the corresponding rates in the younger group were 80.5% and 61.2%, respectively. Grade 3 radiation pneumonitis (RP) was observed in 4.4% patients in the young group, whereas no grade 3 RP was observed in the elderly group. Age was not a risk factor for symptomatic RP. There were no significant differences in the survival and adverse events between the elderly and younger groups. Conclusion: PBT may be a reasonable approach for treating lung cancer in elderly patients with T1-3N0M0 NSCLC.
引用
收藏
页码:2953 / 2960
页数:8
相关论文
共 30 条
[1]   CARBON-ION BEAM IRRADIATION EFFECTIVELY SUPPRESSES MIGRATION AND INVASION OF HUMAN NON-SMALL-CELL LUNG CANCER CELLS [J].
Akino, Yuichi ;
Teshima, Teruki ;
Kihara, Ayaka ;
Kodera-Suzumoto, Yuko ;
Inaoka, Miho ;
Higashiyama, Shigeki ;
Furusawa, Yoshiya ;
Matsuura, Nariaki .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (02) :475-481
[2]   The Impact of Tumor Size on Outcomes After Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Non-Small Cell Lung Cancer [J].
Allibhai, Zishan ;
Taremi, Mojgan ;
Bezjak, Andrea ;
Brade, Anthony ;
Hope, Andrew J. ;
Sun, Alexander ;
Cho, B. C. John .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (05) :1064-1070
[3]   Accelerated reoxygenation of a murine fibrosarcoma after carbon-ion radiation [J].
Ando, K ;
Koike, S ;
Ohira, C ;
Chen, YJ ;
Nojima, K ;
Ando, S ;
Ohbuchi, T ;
Kobayashi, N ;
Shimizu, W ;
Urano, M .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1999, 75 (04) :505-512
[4]   Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease [J].
Bahig, Houda ;
Filion, Edith ;
Vu, Toni ;
Chalaoui, Jean ;
Lambert, Louise ;
Roberge, David ;
Gagnon, Michel ;
Fortin, Bernard ;
Beliveau-Nadeau, Dominic ;
Mathieu, Dominique ;
Campeau, Marie-Pierre .
PRACTICAL RADIATION ONCOLOGY, 2016, 6 (05) :367-374
[5]   Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis [J].
Chi, Alexander ;
Chen, Haiquan ;
Wen, Sijin ;
Yan, Haijuan ;
Liao, Zhongxing .
RADIOTHERAPY AND ONCOLOGY, 2017, 123 (03) :346-354
[6]   Inoperable Early-Stage Non-Small-Cell Lung Cancer: Stereotactic Ablative Radiotherapy and Rationale for Systemic Therapy [J].
Daly, Megan E. .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06) :539-+
[7]   Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT) [J].
Glick, Daniel ;
Lyen, Stephen ;
Kandel, Sonja ;
Shapera, Shane ;
Le, Lisa W. ;
Lindsay, Patricia ;
Wong, Olive ;
Bezjak, Andrea ;
Brade, Anthony ;
Cho, B. C. John ;
Hope, Andrew ;
Sun, Alexander ;
Giuliani, Meredith .
CLINICAL LUNG CANCER, 2018, 19 (02) :E219-E226
[8]   Involved-Node Proton Therapy in Combined Modality Therapy for Hodgkin Lymphoma: Results of a Phase 2 Study [J].
Hoppe, Bradford S. ;
Flampouri, Stella ;
Zaiden, Robert ;
Slayton, William ;
Sandler, Eric ;
Ozdemir, Savas ;
Dang, Nam H. ;
Lynch, James W. ;
Li, Zuofeng ;
Morris, Christopher G. ;
Mendenhall, Nancy P. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 89 (05) :1053-1059
[9]   Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan [J].
Inaniwa, Taku ;
Kanematsu, Nobuyuki ;
Matsufuji, Naruhiro ;
Kanai, Tatsuaki ;
Shirai, Toshiyuki ;
Noda, Koji ;
Tsuji, Hiroshi ;
Kamada, Tadashi ;
Tsujii, Hirohiko .
PHYSICS IN MEDICINE AND BIOLOGY, 2015, 60 (08) :3271-3286
[10]   Particle therapy for prostate cancer: The past, present and future [J].
Ishikawa, Hitoshi ;
Tsuji, Hiroshi ;
Murayama, Shigeyuki ;
Sugimoto, Mikio ;
Shinohara, Nobuo ;
Maruyama, Satoru ;
Murakami, Motohiro ;
Shirato, Hiroki ;
Sakurai, Hideyuki .
INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (10) :971-979